Clin Res Cardiol (2023). https://doi.org/10.1007/s00392-023-02180-w

P-wave duration and interatrial block as predictors of new-onset atrial fibrillation: A systematic review and meta-analysis
S. Nedios1, E. Koutalas2, K. Zagoridis1, S. Intzes1, M. Symeonidou1, E. Kanoupakis2, G. Kochiadakis2, B. Dinov1, N. Dagres3, G. Hindricks3, A. Bollmann1
1Klinik für Innere Medizin/Kardiologie, Herzzentrum Leipzig - Universität Leipzig, Leipzig; 2Kardiologie, Universitätsklinikum Heraklion, Heraklion, GR; 3Rhythmologie, Herzzentrum Leipzig - Universität Leipzig, Leipzig;

Background: Early detection of atrial fibrillation (AF) could improve patient outcomes. P-wave duration (PWD) and interatrial block (IAB) are known predictors of new-onset AF and could improve selection for AF screening. This meta-analysis reviews the published evidence and offers practical implications.

Methods: Publication databases were systematically searched and studies reporting PWD and/or morphology at baseline and new-onset AF during follow-up were included. IAB was defined as partial (pIAB) if PWD≥120 ms or advanced (aIAB) if the P-wave was biphasic in the inferior leads. After quality assessment and data extraction, random-effects analysis calculated odds ratio (OR) and confidence intervals (CI). Subgroup analysis was performed for those with implantable devices (continuous monitoring).

Results: Among 16.830 patients (13 studies, mean 66 years old), 2.521 (15%) had new-onset AF over a median of 44 months. New-onset AF was associated with a longer PWD (mean pooled difference: 11.5 ms, 13 studies, p<0.001). The OR for new-onset AF was 2.05 (95% CI: 1.3-3.2) for pIAB (5 studies, p=0.002) and 3.9 (95% CI: 2.6-5.8) for aIAB (7 studies, p<0.001). Patients with pIAB and devices had higher AF-detection risk (OR: 2.33, p<0.001) than those without devices (OR: 1.36, p=0.56). Patients with aIAB had similarly high risk regardless of device presence. There was significant heterogeneity but no publication bias.

Conclusion: Interatrial block is an independent predictor of new-onset AF. The association is stronger for patients with implantable devices (close monitoring). Thus, PWD and IAB could be used as selection criteria for intensive screening, follow-up or interventions.


https://dgk.org/kongress_programme/jt2023/aP472.html